Rearrangement of a (dithiolato)platinum(II) complex formed by reaction of cyclic disulfide 7,8-dithiabicyclo[4.2.1]nona-2,4-diene with a platinum(0) complex: oxidation of the rearranged (dithiolato)platinum(II) complex

Reaction of the title bicyclic disulfide 16 with [(Ph3P)2Pt(eta2-C2H4)] (2) yielded the corresponding (dithiolato)platinum(II) complex 17 by oxidative addition. The initial product 17 isomerized at room temperature in a [1,5]-sulfur rearrangement to give another (dithiolato)platinum(II) complex 18 in high isolated yield. Oxidation reactions of 18 with dimethyldioxirane (DMD) provided (sulfenato-thiolato)platinum(II) 23, (sulfinato-thiolato)platinum(II) 24, (sulfenato-sulfinato)platinum(II) 25, and (disulfinato)platinum(II) 26 complexes, the structures of which were elucidated by NMR spectroscopy and X-ray crystallography. The oxidation process took place regioselectively in the first step and chemoselectively in the second. The selectivities are discussed.     

Synthesis, structure and antitumor activity of a water-soluble platinum complex, (1R,3R,4R,5R)-(-)-quinato(1R,2R-cyclohexanediamine)platinum (II).

The reaction of dihydroxo(1R,2R-cyclohexanediamine)platinum(II) with (-)-quinic acid gave a water soluble complex, (-)-quinato(1R,2R-cyclohexanediamine)platinum(II). The crystal structure of the complex was determined by X-ray analysis. The data indicate a chelation of the alpha-hydroxycarboxylic acid part of quinic acid to platinum(II). The complex shows moderate antitumor activity against murine leukemia L1210 at high doses (T/C x 100 = 179% at a dose of 200 mg/kg).     

Synthesis and Opto‐electronic Properties of a Red‐Emitting Heteroleptic Platinum Complex Using Pyrazol‐based Diketone Derivative as Ancillary Ligand

A red‐emitting heteroleptic cyclometalated platinum(II) complex containing an ancillary ligand of pyrazol‐based diketone derivative was synthesized. Its optophysical and electroluminescent properties were studied. Compared to the reported (piq)Pt(acac) complex, this platinum(II) complex exhibited a blue‐shifted UV absorption band at 300–450 nm, a low LUMO energy level and improved electroluminescent property. Using this platinum(II) complex as a single doping emitter and a blend of ploy(9,9‐dioctylfluorene) and 2‐tert‐butylphenyl‐5‐phenyl‐1,3,4‐oxadiazole as a host matrix, the fabricated polymer light‐emitting devices displayed saturated red emission with a peak at 648 nm and a shoulder at 601 nm. Furthermore, the emission quenching of the platinum(II) complex was significantly suppressed in these devices at high current density due to an introduction of the non‐planar pyrazol group into the ancillary ligand.     

Organoplatinum(II) complexes containing chelating or bridging bis(N-heterocyclic carbene) ligands: formation of a platinum(II) carbonate complex by aerial CO2 fixation

The preparation of two new bis(N-heterocyclic carbene) platinum(II) complexes, in which NHC rings are joined by a CH(2) linker group, is described. While, the chelate complex [PtMe(2)(bis-NHC1)], 1, was formed with large tert-butyl wingtips, the iso-propyl N-substituent analogue favors formation of the cluster complex [Pt(2)Me(4)(μ-SMe(2))(μ-bis-NHC2)](2)(μ-Ag(2)Br(2)), 2, in which two binuclear platinum(II) complexes are linked together by an Ag(2)Br(2) unit. The chelating platinum complex 1 undergoes aerial CO(2) fixation and forms platinum(II) carbonate complex [Pt(CO(3))(bis-NHC1)], 3.     

Determination of platinum and iridium in reforming catalysts by second derivative and absorptiometric spectrophotometry

Summary Investigations on the spectrophotometric determination of platinum as a complex formed by tin(II)chloride in hydrochloric acid are reported. The determination of platinum was found to be interfered with by iridium, because it also forms a complex with tin(II) chloride. The features of the derivative absorption spectrophotometry for the quantitative determination of platinum and iridium was also studied. The analytical application of the method for the determination of platinum and iridium in catalysts was investigated.     

Thermal and spectroscopic investigation of new binuclear Pt(II) complexes with carboxylic acids

The thermal decomposition of the binuclear Pt(II) complexes with acetate, propionate, valerate and izovalerate ligands were studied by TG and DTA techniques. The Pt(II) complex with acetic acid (PtAA) was stable up to 343.15 K, Pt(II) complex with propionic acid (PtPrA) was stable up to 323.15 K, Pt(II) complex with valeric acid (PtVA) was stable up to T=313.15 K and Pt(II) complex with isovaleric acid (PtIvA) was stable up to 408.15 K. The PtAA complex was investigated again after a year by thermogravimetric analysis. After the thermal decomposition of the Pt(II) complexes with carboxylic acids, only in the PtVA complex and PtAA complex (investigated after a year) the final residue contains only platinum, while in the rest complexes the solid residue was a mixture of platinum and platinum carbides (PtC₂, Pt₂C₃).     

Organic vapor triggered repeatable on-off crystalline-state luminescence switching

A nonporous crystalline solid consisting of an organoarsenic platinum(II) complex, i.e., a mononuclear diiodoplatinum(II) complex trans-PtI(2)(cis-DHDAtBu)(2) (1) with cis-1,4-dihydro-1,4-dimethyl-2,3,5,6-tetrakis(tert-butoxycarbonyl)-1,4-diarsinine (cis-DHDAtBu), shows on-off solid-state luminescence switching through reversible solvent vapor uptake and escape. The on-off switching of solid-state luminescence was achieved without changing the structure or electronic state of the organoarsenic platinum(II) complex.     

Diastereoselective assembling of 21-C-alkylated nickel(II) complexes of inverted porphyrin on a platinum(II) template

Reaction of 21-C-methyl and 21-C-benzyl nickel(II) complexes of inverted meso-tetratolylporphyrin with platinum(II) dichloride or its bis(benzonitrile) complex yields a chloroplatinum(II) species containing two nickel(II) carbaporphyrinoids in a cis arrangement. One of the carbaporphyrinoids coordinates to the platinum ion with the external nitrogen while the other is bound with the external nitrogen and one ortho-carbon of the adjacent meso-aryl ring. The reaction is highly chemoselective. (1)H and (13)C NMR experiments in solution show the diastereoselectivity of the reaction. Single-crystal X-ray data confirm the presence of the diastereomer with opposite configurations of the Ni(II)-coordinated carbons in the subunits of the dimer. Cyclovoltammetric measurements reveal an anodic shift of the nickel(II) oxidation potentials of dimers with respect to those of the parent monomers and two different reduction couples. Reaction of unsubstituted inverted porphyrin with Pt(PhCN)(2)Cl(2) in chlorobenzene yields a monomeric platinum(II) complex of inverted porphyrin. This complex displays a markedly upfield (195)Pt NMR shift compared to tetraphenylporphyrinatoplatinum(II). Under strongly basic conditions deprotonation of the external nitrogen of inverted porphyrin and both electrochemical and chemical oxidation of platinum(II) center are observed.     

New S/O-substituted ferrocenediyl ligands and their metal complexes

New unsymmetrical S/O 1,1'-disubstituted ferrocenediyl ethers and hydroxides have been synthesised. The coordination chemistry of 1-(methylsulfanyl)-1'-(methoxy)ferrocene has been investigated with palladium(II) and platinum(II) precursors. With palladium(II), a bis-mu-chloro-bridged dimeric complex was obtained with the ligand bound solely through the thioether donor group. With platinum(II), a bis-ligand trans-sulfur ligated complex was obtained and structurally characterised.     

An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(II) metallo-drug

A range of androgen conjugates with non-conventional platinum(II) complexes have been synthesised with the aim of targeting tumour cells since many display elevated levels of the androgen receptor. The androgenic platinum conjugates are delivered into selected cells with improved efficiency (when compared to their non-steroidal analogues). The act of conjugating an androgen to a platinum(II) complex resulted in synergistic effects between the metallic centre and the steroidal ligand, creating highly potent platinum(II) complexes from the inactive components.     

Dialkyl bisphosphonate platinum(II) complex as a potential drug for metastatic bone tumor

Bisphosphonates have high affinity for hydroxyapatite (HA), which is abundantly present in bone. Also, platinum complexes are known that have a wide spectrum of antitumor activities. The conjugate of bisphosphonate and a platinum complex might have HA affinity and antitumor activity, and become a drug for metastatic bone tumor. In this study, the authors synthesized platinum complexes that had dialkyl bisphosphonic acid as a ligand, and evaluated the possibility of the synthesized complexes as a drug for metastatic bone tumor. The synthesized dialkyl bisphosphonate platinum(II) complex was characterized, and its stability in an aqueous solution was also confirmed. The synthesized platinum complex showed higher HA affinity than other platinum complexes such as cisplatin and carboplatin in an experiment of adsorption to HA. In vitro, the platinum complex showed tumor growth inhibitory effect stronger than or equal to cisplatin, which is the most commonly used antitumor agent. Moreover, the platinum complex showed a bone absorption inhibitory effect on the osteoclast. These results suggest potential of dialkyl bisphosphonate platinum(II) complexes as a drug for metastatic bone tumor.     

"Proof-of-principle" concept for label-free detection of glucose and α-glucosidase activity through the electrostatic assembly of alkynylplatinum(II) terpyridyl complexes

A two-component platinum(II) complex-polymer ensemble has been demonstrated for label-free spectroscopic detection of glucose and α-glucosidase activity, based on the electrostatic assembly of cationic platinum(II) complex molecules onto a glucose-bound anionic polymer.     

A Redox‐Activated G‐Quadruplex DNA Binder Based on a Platinum(IV)–Salphen Complex

There has been increasing interest in the development of small molecules that can selectively bind to G‐quadruplex DNA structures. The latter have been associated with a number of key biological processes and therefore are proposed to be potential targets for drug development. Herein, we report the first example of a reduction‐activated G‐quadruplex DNA binder. We show that a new octahedral platinum(IV)–salphen complex does not interact with DNA in aqueous media at pH 7.4; however, upon addition of bioreductants such as ascorbic acid or glutathione, the compound is readily reduced to the corresponding square planar platinum(II) complex. In contrast to the parent platinum(IV) complex, the in situ generated platinum(II) complex has good affinity for G‐quadruplex DNA.     

The thermal degradation characteristics of selected organoplatinum antitumor agents

The thermal decomposition characteristics of representatives of three classes of organoplatinum compounds have been examined by thermogravimetry. Substituted salicylato(1,2-diaminocyclohexane)platinum(II) compounds undergo thermal decomposition by sequential loss of first the salicylato ligand and then the amine ligand to afford a residue corresponding to the platinum content of the compound. The thermal decomposition of N-arylsalicylaldimino(1,2-diaminocyclohexane)platinum(II) nitrate is more complex, but is also characterized by two major weight losses. Thermal decomposition ofbis-(2-thiophenecarboxylato)platinum(II) is characterized by ligand fragmentation to generate a residual mass corresponding to the platinum content of the compound.     

Five-coordinate platinum(IV) complex as a precursor to a novel Pt(II) olefin hydride complex for alkane activation

The five-coordinate platinum(IV) complex (nacnac)PtMe3 (nacnac- = [{(o-iPr2C6H3)NC(CH3)}2CH]-) thermally eliminates ethane and methane to produce a novel olefin(hydrido)platinum(II) complex, where the olefin is part of the nacnac-type ligand. This Pt(II) product activates hydrocarbons, including alkanes under mild conditions, as indicated by scrambling of hydrogen and deuterium between the hydrocarbon solvent and selected positions on the ligand of the platinum complex. A mechanism in which olefin insertion into the metal hydride bond opens a site to allow hydrocarbon coordination and C-H bond oxidative addition is proposed.     

Synthesis and biological evaluation of new mono naphthalimide platinum(IV) derivatives as antitumor agents with dual DNA damage mechanism

Naphthalimide has emerged as an interesting DNA intercalator and possessed attracting antitumor properties. In this context, naphthalimide group was linked to platinum(IV) core to construct a series of new mono naphthalimide platinum(IV) derivatives. The title compounds exert effective antitumor activities to the tested tumor cells lines in vitro, especially the one with propionyl chain displays comparable or even better bioactivities than platinum(II) reference drugs cisplatin and oxaliplatin. Moreover, the mono naphthalimide platinum(IV) derivative displays comparable tumor growth inhibitory competence against CT26 xenograft tumors in BALB/c mice in vivo without severe toxic effects in contrast to oxaliplatin. A dual DNA damage mechanism was proven for the title complex. Both naphthalimide ligand and the liberated platinum(II) moiety could generate DNA lesions to tumor cells synergistically and active the apoptotic pathway by up-regulating the expression of caspase 9 and caspase 3. Meanwhile, the conversion of platinum(II) drug into tetravalent form by incorporating naphthalimide moiety increases the uptake of platinum in whole cells and DNA remarkably. All these facts might be the factors for the title platinum(IV) complexes to overcome platinum(II) drug resistance. Additionally, the mono naphthalimide platinum(IV) complex could interact with human serum albumin by hydrogen bond and van der Waals force which would further influence their storage, transport and bioactivities.     

Noncovalent Axial I⋅⋅⋅Pt⋅⋅⋅I Interactions in Platinum(II) Complexes Strengthen in the Excited State

Coordination compounds of platinum(II) participate in various noncovalent axial interactions involving metal center. Weakly bound axial ligands can be electrophilic or nucleophilic; however, interactions with nucleophiles are compromised by electron density clashing. Consequently, simultaneous axial interaction of platinum(II) with two nucleophilic ligands is almost unprecedented. Herein, we report structural and computational study of a platinum(II) complex possessing such intramolecular noncovalent I⋅⋅⋅Pt⋅⋅⋅I interactions. Structural analysis indicates that the two iodine atoms approach the platinum(II) center in a “side-on” fashion and act as nucleophilic ligands. According to computational studies, the interactions are dispersive, weak and anti-cooperative in the ground electronic state, but strengthen substantially and become partially covalent and cooperative in the lowest excited state. Strengthening of I⋅⋅⋅Pt⋅⋅⋅I contacts in the excited state is also predicted for the sole previously reported complex with analogous axial interactions.     

双马来腈二亚胺合铂与DNA的作用

本文以紫外-可见光谱、荧光光谱及黏度法研究了双马来腈二亚胺合铂与DNA的作用。紫外-可见光谱的研究表明,与DNA作用后,双马来腈二亚胺合铂在可见区的吸收显示出了减色效应,并伴随着吸收峰的蓝移。Scatchard图的分析结果表明,双马来腈二亚胺合铂与DNA的作用位点与溴化乙锭不同。黏度法实验表明,双马来腈二亚胺合铂与DNA作用后降低了DNA的相对黏度。这些研究结果表明,双马来腈二亚胺合铂以静电作用方式与DNA结合。本研究有助于深入理解双马来腈二亚胺合铂的作用机理并开发这种潜在的新型光动力治疗剂。     

Synthesis and structure of an unexpected platinum pi complex formed from substituted 1,4-diamino ligands through an elimination process

An unusual reactivity of cis-1,2-bis[(N,N-dimethylamino)methyl] cyclohexane with PtCl(2) was observed, resulting in the formation of a platinum(II) pi-olefin complex instead of the conventional square-planar cis Pt(II) coordination complex with the diamino ligand. This behavior was interpreted on the basis of the steric hindrance of the dimethylamino groups whose electron lone pairs are barely accessible to a platinum atom, which can make it difficult for both dimethylamino groups to bind platinum at the same time. This complex has been physically and spectroscopically characterized and its structure has been confirmed by using X-ray diffraction analyses on single crystals.     

Hydrogen bonding directs the H2O2 oxidation of platinum(II) to a cis-dihydroxo platinum(IV) complex

The use of ligands with proximate hydrogen bonding substituents in the oxidation of platinum(II) dimethyl complexes with H2O2 leads to the exclusive formation of an unusual cis-dihydroxo platinum(IV) complex, which can dehydrate to form a trinuclear metalla-azacrown complex.